M. Meissner
Velindre NHS Trust(GB)Velindre Cancer Centre(GB)
Research Areas
Particle physics theoretical and experimental studies, Quantum Chromodynamics and Particle Interactions, High-Energy Particle Collisions Research, Virus-based gene therapy research, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → 1585TiP A phase I study of ATTR-01, a novel oncolytic adenovirus targeting αvβ6 integrin, which expresses the anti-PD-L1 antibody payload in tumour following intravenous delivery in patients with selected epithelial tumours(2025)
- → 577 A phase 1 study of ATTR-01, a novel oncolytic adenovirus targeting αvβ6 integrin, which expresses an anti-PD-L1 antibody in tumors following IV delivery in patients with selected epithelial cancers(2025)
- → A Phase 1-2 Master Protocol to Study Intravenous ATTR-01 in Adult Participants with Select Epithelial Solid Tumours Under Multiple sub-protocols (ATTEST)(2025)